Share Price and Basic Stock Data
Last Updated: October 10, 2025, 8:57 pm
| PEG Ratio | 2.23 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Foseco India Ltd operates within the chemicals sector, specifically in organic chemicals, showcasing a robust business model. As of the latest data, the company’s stock price stands at ₹5,586, with a market capitalization of ₹3,605 Cr. Over the past few quarters, Foseco has demonstrated steady revenue growth, with sales rising from ₹100 Cr in June 2022 to ₹123 Cr by September 2023, indicating a compound annual growth rate (CAGR) of approximately 11.5%. This upward trajectory is expected to continue, with projections indicating sales of ₹157 Cr by June 2025. The company’s operational performance is further supported by a positive operating profit margin (OPM) of 17%, reflecting effective cost management strategies. This consistent revenue growth outpaces the sector average, which typically hovers around 10%, positioning Foseco favorably against its peers.
Profitability and Efficiency Metrics
Foseco India Ltd showcases impressive profitability metrics, highlighted by a net profit of ₹73 Cr for the year ending December 2023, translating to an earnings per share (EPS) of ₹114.28. The company’s return on equity (ROE) is notably high at 23.3%, while the return on capital employed (ROCE) stands at an impressive 31.3%, both of which exceed many industry benchmarks. The company’s operational efficiency is further evidenced by a cash conversion cycle (CCC) of -23 days, indicating that it collects cash from customers before it pays its suppliers. This efficiency is crucial in the chemicals industry, where operational cash flow can significantly impact overall profitability. Furthermore, Foseco’s interest coverage ratio (ICR) is an extraordinary 1246.69x, indicating negligible debt and a strong ability to manage any potential financial obligations.
Balance Sheet Strength and Financial Ratios
The balance sheet of Foseco India Ltd reflects a solid financial position, with total reserves amounting to ₹363 Cr and negligible borrowings at just ₹2 Cr. This minimal debt load enhances the company’s financial stability, especially in a volatile market. The price-to-book value (P/BV) ratio of 8.52x suggests that the market has high expectations for future growth, although it also indicates that the stock may be overvalued compared to its underlying assets. The current ratio, standing at 2.84, and the quick ratio of 2.59, further underscore the company’s liquidity position, comfortably above the industry average of around 1.5. These ratios indicate that Foseco is well-equipped to meet its short-term liabilities, ensuring operational continuity even during economic downturns.
Shareholding Pattern and Investor Confidence
Foseco India Ltd’s shareholding pattern reveals a strong confidence from its promoters, who hold 74.98% of the equity. This high level of promoter ownership often signals to investors a commitment to the company’s long-term success. Institutional interest, however, is minimal, with foreign institutional investors (FIIs) holding only 0.15% and domestic institutional investors (DIIs) at 0.59%. This could reflect either a lack of awareness of the company’s growth potential or a cautious approach towards the chemicals sector amid broader market uncertainties. The public shareholding stands at 24.28%, with a total of 13,019 shareholders, indicating a relatively engaged retail investor base. As the company continues to perform well, increased awareness and interest from institutional investors could further bolster its stock performance.
Outlook, Risks, and Final Insight
Looking ahead, Foseco India Ltd appears well-positioned for sustained growth, driven by its strong profitability metrics and robust balance sheet. However, potential risks include fluctuating raw material prices, which could impact margins, and the overall economic environment that could affect demand within the chemicals sector. The company’s high P/BV ratio suggests that it may be priced for perfection, which could pose risks if future earnings do not meet market expectations. Nevertheless, with projected sales growth and a commitment to operational efficiency, Foseco presents a compelling investment opportunity. Investors should monitor the company’s ability to maintain its competitive edge and manage external risks effectively, ensuring that it continues to deliver value to its shareholders.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Foseco India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 113 Cr. | 317 | 530/255 | 117 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,776 Cr. | 9,808 | 14,980/8,150 | 58.5 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 38.4 Cr. | 128 | 329/114 | 15.5 | 24.9 | 0.78 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.0 Cr. | 35.8 | 35.8/0.00 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| Archit Organosys Ltd | 94.4 Cr. | 46.0 | 51.4/34.2 | 15.5 | 33.7 | 1.09 % | 10.8 % | 7.62 % | 10.0 |
| Industry Average | 4,821.38 Cr | 1,760.96 | 432.65 | 340.62 | 0.38% | 14.38% | 10.33% | 7.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 103 | 106 | 111 | 121 | 123 | 122 | 123 | 125 | 141 | 136 | 149 | 157 |
| Expenses | 85 | 88 | 88 | 95 | 103 | 107 | 103 | 103 | 101 | 117 | 114 | 121 | 130 |
| Operating Profit | 14 | 15 | 18 | 15 | 18 | 16 | 20 | 20 | 24 | 24 | 23 | 27 | 27 |
| OPM % | 14% | 15% | 17% | 14% | 15% | 13% | 16% | 16% | 19% | 17% | 17% | 18% | 17% |
| Other Income | 1 | 2 | 2 | 5 | 17 | 7 | 5 | 4 | 4 | 4 | 6 | 4 | 4 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 2 |
| Profit before tax | 14 | 15 | 16 | 19 | 33 | 21 | 22 | 21 | 25 | 26 | 26 | 29 | 29 |
| Tax % | 26% | 26% | 25% | 26% | 17% | 29% | 25% | 25% | 26% | 26% | 26% | 26% | 26% |
| Net Profit | 11 | 11 | 12 | 14 | 28 | 15 | 16 | 16 | 18 | 19 | 20 | 22 | 22 |
| EPS in Rs | 16.53 | 17.11 | 19.20 | 22.30 | 43.31 | 23.13 | 25.54 | 24.82 | 28.97 | 29.95 | 30.61 | 33.93 | 33.71 |
Last Updated: August 1, 2025, 9:20 pm
Below is a detailed analysis of the quarterly data for Foseco India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 157.00 Cr.. The value appears strong and on an upward trend. It has increased from 149.00 Cr. (Mar 2025) to 157.00 Cr., marking an increase of 8.00 Cr..
- For Expenses, as of Jun 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 121.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 9.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For OPM %, as of Jun 2025, the value is 17.00%. The value appears to be declining and may need further review. It has decreased from 18.00% (Mar 2025) to 17.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
- For Net Profit, as of Jun 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 33.71. The value appears to be declining and may need further review. It has decreased from 33.93 (Mar 2025) to 33.71, marking a decrease of 0.22.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 5:32 pm
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 227 | 263 | 292 | 340 | 358 | 362 | 323 | 251 | 338 | 407 | 477 | 525 | 551 |
| Expenses | 196 | 224 | 241 | 285 | 306 | 312 | 276 | 230 | 294 | 343 | 408 | 434 | 453 |
| Operating Profit | 31 | 39 | 51 | 55 | 51 | 51 | 46 | 21 | 44 | 63 | 70 | 91 | 98 |
| OPM % | 13% | 15% | 17% | 16% | 14% | 14% | 14% | 8% | 13% | 16% | 15% | 17% | 18% |
| Other Income | 2 | 3 | 2 | 2 | 3 | 4 | 8 | 6 | 6 | 7 | 33 | 18 | 19 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 6 | 6 | 9 | 8 | 10 | 10 |
| Profit before tax | 27 | 38 | 48 | 51 | 48 | 50 | 50 | 21 | 43 | 61 | 95 | 98 | 106 |
| Tax % | 34% | 35% | 34% | 36% | 34% | 36% | 30% | 27% | 25% | 25% | 23% | 26% | |
| Net Profit | 18 | 25 | 32 | 33 | 32 | 32 | 35 | 15 | 33 | 46 | 73 | 73 | 79 |
| EPS in Rs | 27.90 | 38.50 | 49.68 | 51.80 | 49.43 | 50.17 | 54.07 | 24.18 | 51.15 | 71.98 | 114.27 | 114.35 | 123.46 |
| Dividend Payout % | 88% | 55% | 53% | 44% | 51% | 50% | 46% | 62% | 49% | 56% | 22% | 22% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 16% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 16% |
| 3 Years: | 31% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 39% |
| 3 Years: | 52% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 20% |
| 3 Years: | 23% |
| Last Year: | 23% |
Last Updated: September 5, 2025, 4:15 am
Balance Sheet
Last Updated: October 10, 2025, 2:02 pm
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 83 | 91 | 103 | 118 | 139 | 150 | 165 | 176 | 202 | 233 | 280 | 337 | 363 |
| Borrowings | 8 | 6 | 4 | 2 | 1 | -0 | -0 | -0 | -0 | -0 | 1 | 2 | 2 |
| Other Liabilities | 50 | 48 | 50 | 57 | 75 | 82 | 77 | 80 | 86 | 106 | 132 | 138 | 150 |
| Total Liabilities | 147 | 152 | 163 | 183 | 221 | 238 | 249 | 263 | 294 | 345 | 420 | 483 | 522 |
| Fixed Assets | 28 | 26 | 26 | 26 | 23 | 20 | 34 | 31 | 35 | 31 | 39 | 45 | 44 |
| CWIP | -0 | 1 | 1 | 0 | 1 | 6 | 2 | 5 | 0 | 1 | 1 | 2 | 1 |
| Investments | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Other Assets | 119 | 125 | 136 | 157 | 197 | 213 | 213 | 227 | 259 | 313 | 379 | 436 | 476 |
| Total Assets | 147 | 152 | 163 | 183 | 221 | 238 | 249 | 263 | 294 | 345 | 420 | 483 | 522 |
Below is a detailed analysis of the balance sheet data for Foseco India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Equity Capital, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 6.00 Cr..
- For Reserves, as of Jun 2025, the value is 363.00 Cr.. The value appears strong and on an upward trend. It has increased from 337.00 Cr. (Dec 2024) to 363.00 Cr., marking an increase of 26.00 Cr..
- For Borrowings, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
- For Other Liabilities, as of Jun 2025, the value is 150.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 138.00 Cr. (Dec 2024) to 150.00 Cr., marking an increase of 12.00 Cr..
- For Total Liabilities, as of Jun 2025, the value is 522.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 483.00 Cr. (Dec 2024) to 522.00 Cr., marking an increase of 39.00 Cr..
- For Fixed Assets, as of Jun 2025, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Dec 2024) to 44.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Dec 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Other Assets, as of Jun 2025, the value is 476.00 Cr.. The value appears strong and on an upward trend. It has increased from 436.00 Cr. (Dec 2024) to 476.00 Cr., marking an increase of 40.00 Cr..
- For Total Assets, as of Jun 2025, the value is 522.00 Cr.. The value appears strong and on an upward trend. It has increased from 483.00 Cr. (Dec 2024) to 522.00 Cr., marking an increase of 39.00 Cr..
Notably, the Reserves (363.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 23.00 | 33.00 | 47.00 | 53.00 | 50.00 | 51.00 | 46.00 | 21.00 | 44.00 | 63.00 | 69.00 | 89.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 101 | 113 | 107 | 103 | 88 | 82 | 94 | 80 | 76 | 78 | 84 |
| Inventory Days | 32 | 32 | 35 | 35 | 29 | 36 | 39 | 32 | 43 | 32 | 46 | 47 |
| Days Payable | 86 | 73 | 80 | 81 | 109 | 111 | 130 | 173 | 136 | 146 | 160 | 155 |
| Cash Conversion Cycle | 49 | 60 | 68 | 61 | 23 | 12 | -8 | -46 | -13 | -37 | -36 | -23 |
| Working Capital Days | 49 | 56 | 72 | 70 | 45 | 31 | 20 | 3 | 21 | 11 | 9 | 24 |
| ROCE % | 29% | 38% | 45% | 44% | 36% | 33% | 30% | 12% | 22% | 28% | 32% | 31% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 114.28 | 71.98 | 51.16 | 24.17 | 54.07 |
| Diluted EPS (Rs.) | 114.28 | 71.98 | 51.16 | 24.17 | 54.07 |
| Cash EPS (Rs.) | 126.48 | 85.92 | 60.36 | 33.42 | 60.64 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 448.78 | 374.25 | 326.73 | 285.99 | 268.36 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 448.78 | 374.25 | 326.73 | 285.99 | 268.36 |
| Dividend / Share (Rs.) | 25.00 | 40.00 | 25.00 | 15.00 | 15.00 |
| Revenue From Operations / Share (Rs.) | 747.53 | 636.87 | 529.26 | 393.25 | 505.01 |
| PBDIT / Share (Rs.) | 142.70 | 109.97 | 77.04 | 42.28 | 84.28 |
| PBIT / Share (Rs.) | 130.50 | 96.03 | 67.83 | 33.02 | 77.71 |
| PBT / Share (Rs.) | 148.99 | 96.03 | 67.83 | 33.02 | 77.71 |
| Net Profit / Share (Rs.) | 114.28 | 71.98 | 51.16 | 24.17 | 54.07 |
| PBDIT Margin (%) | 19.08 | 17.26 | 14.55 | 10.75 | 16.68 |
| PBIT Margin (%) | 17.45 | 15.07 | 12.81 | 8.39 | 15.38 |
| PBT Margin (%) | 19.93 | 15.07 | 12.81 | 8.39 | 15.38 |
| Net Profit Margin (%) | 15.28 | 11.30 | 9.66 | 6.14 | 10.70 |
| Return on Networth / Equity (%) | 25.46 | 19.23 | 15.65 | 8.45 | 20.14 |
| Return on Capital Employeed (%) | 28.89 | 25.55 | 20.70 | 11.50 | 28.82 |
| Return On Assets (%) | 17.39 | 13.31 | 11.09 | 5.86 | 13.88 |
| Asset Turnover Ratio (%) | 1.25 | 1.27 | 1.21 | 0.98 | 1.32 |
| Current Ratio (X) | 2.84 | 2.91 | 2.98 | 2.74 | 2.70 |
| Quick Ratio (X) | 2.59 | 2.72 | 2.72 | 2.58 | 2.44 |
| Inventory Turnover Ratio (X) | 9.37 | 10.15 | 10.47 | 8.17 | 8.90 |
| Dividend Payout Ratio (NP) (%) | 35.00 | 34.73 | 19.54 | 20.68 | 46.23 |
| Dividend Payout Ratio (CP) (%) | 31.62 | 29.09 | 16.56 | 14.95 | 41.22 |
| Earning Retention Ratio (%) | 65.00 | 65.27 | 80.46 | 79.32 | 53.77 |
| Cash Earning Retention Ratio (%) | 68.38 | 70.91 | 83.44 | 85.05 | 58.78 |
| Interest Coverage Ratio (X) | 1246.69 | 0.00 | 0.00 | 38571.14 | 41404.69 |
| Interest Coverage Ratio (Post Tax) (X) | 836.82 | 0.00 | 0.00 | 22053.57 | 26564.77 |
| Enterprise Value (Cr.) | 2210.85 | 1039.64 | 758.83 | 700.49 | 722.16 |
| EV / Net Operating Revenue (X) | 4.63 | 2.56 | 2.24 | 2.79 | 2.24 |
| EV / EBITDA (X) | 24.26 | 14.80 | 15.42 | 25.94 | 13.42 |
| MarketCap / Net Operating Revenue (X) | 5.11 | 3.02 | 2.69 | 3.33 | 2.59 |
| Retention Ratios (%) | 64.99 | 65.26 | 80.45 | 79.31 | 53.76 |
| Price / BV (X) | 8.52 | 5.14 | 4.35 | 4.59 | 4.87 |
| Price / Net Operating Revenue (X) | 5.11 | 3.02 | 2.69 | 3.33 | 2.59 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.01 | 0.04 |
After reviewing the key financial ratios for Foseco India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Dec 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Dec 23, the value is 114.28. This value is within the healthy range. It has increased from 71.98 (Dec 22) to 114.28, marking an increase of 42.30.
- For Diluted EPS (Rs.), as of Dec 23, the value is 114.28. This value is within the healthy range. It has increased from 71.98 (Dec 22) to 114.28, marking an increase of 42.30.
- For Cash EPS (Rs.), as of Dec 23, the value is 126.48. This value is within the healthy range. It has increased from 85.92 (Dec 22) to 126.48, marking an increase of 40.56.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 448.78. It has increased from 374.25 (Dec 22) to 448.78, marking an increase of 74.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 448.78. It has increased from 374.25 (Dec 22) to 448.78, marking an increase of 74.53.
- For Dividend / Share (Rs.), as of Dec 23, the value is 25.00. This value exceeds the healthy maximum of 3. It has decreased from 40.00 (Dec 22) to 25.00, marking a decrease of 15.00.
- For Revenue From Operations / Share (Rs.), as of Dec 23, the value is 747.53. It has increased from 636.87 (Dec 22) to 747.53, marking an increase of 110.66.
- For PBDIT / Share (Rs.), as of Dec 23, the value is 142.70. This value is within the healthy range. It has increased from 109.97 (Dec 22) to 142.70, marking an increase of 32.73.
- For PBIT / Share (Rs.), as of Dec 23, the value is 130.50. This value is within the healthy range. It has increased from 96.03 (Dec 22) to 130.50, marking an increase of 34.47.
- For PBT / Share (Rs.), as of Dec 23, the value is 148.99. This value is within the healthy range. It has increased from 96.03 (Dec 22) to 148.99, marking an increase of 52.96.
- For Net Profit / Share (Rs.), as of Dec 23, the value is 114.28. This value is within the healthy range. It has increased from 71.98 (Dec 22) to 114.28, marking an increase of 42.30.
- For PBDIT Margin (%), as of Dec 23, the value is 19.08. This value is within the healthy range. It has increased from 17.26 (Dec 22) to 19.08, marking an increase of 1.82.
- For PBIT Margin (%), as of Dec 23, the value is 17.45. This value is within the healthy range. It has increased from 15.07 (Dec 22) to 17.45, marking an increase of 2.38.
- For PBT Margin (%), as of Dec 23, the value is 19.93. This value is within the healthy range. It has increased from 15.07 (Dec 22) to 19.93, marking an increase of 4.86.
- For Net Profit Margin (%), as of Dec 23, the value is 15.28. This value exceeds the healthy maximum of 10. It has increased from 11.30 (Dec 22) to 15.28, marking an increase of 3.98.
- For Return on Networth / Equity (%), as of Dec 23, the value is 25.46. This value is within the healthy range. It has increased from 19.23 (Dec 22) to 25.46, marking an increase of 6.23.
- For Return on Capital Employeed (%), as of Dec 23, the value is 28.89. This value is within the healthy range. It has increased from 25.55 (Dec 22) to 28.89, marking an increase of 3.34.
- For Return On Assets (%), as of Dec 23, the value is 17.39. This value is within the healthy range. It has increased from 13.31 (Dec 22) to 17.39, marking an increase of 4.08.
- For Asset Turnover Ratio (%), as of Dec 23, the value is 1.25. It has decreased from 1.27 (Dec 22) to 1.25, marking a decrease of 0.02.
- For Current Ratio (X), as of Dec 23, the value is 2.84. This value is within the healthy range. It has decreased from 2.91 (Dec 22) to 2.84, marking a decrease of 0.07.
- For Quick Ratio (X), as of Dec 23, the value is 2.59. This value exceeds the healthy maximum of 2. It has decreased from 2.72 (Dec 22) to 2.59, marking a decrease of 0.13.
- For Inventory Turnover Ratio (X), as of Dec 23, the value is 9.37. This value exceeds the healthy maximum of 8. It has decreased from 10.15 (Dec 22) to 9.37, marking a decrease of 0.78.
- For Dividend Payout Ratio (NP) (%), as of Dec 23, the value is 35.00. This value is within the healthy range. It has increased from 34.73 (Dec 22) to 35.00, marking an increase of 0.27.
- For Dividend Payout Ratio (CP) (%), as of Dec 23, the value is 31.62. This value is within the healthy range. It has increased from 29.09 (Dec 22) to 31.62, marking an increase of 2.53.
- For Earning Retention Ratio (%), as of Dec 23, the value is 65.00. This value is within the healthy range. It has decreased from 65.27 (Dec 22) to 65.00, marking a decrease of 0.27.
- For Cash Earning Retention Ratio (%), as of Dec 23, the value is 68.38. This value is within the healthy range. It has decreased from 70.91 (Dec 22) to 68.38, marking a decrease of 2.53.
- For Interest Coverage Ratio (X), as of Dec 23, the value is 1,246.69. This value is within the healthy range. It has increased from 0.00 (Dec 22) to 1,246.69, marking an increase of 1,246.69.
- For Interest Coverage Ratio (Post Tax) (X), as of Dec 23, the value is 836.82. This value is within the healthy range. It has increased from 0.00 (Dec 22) to 836.82, marking an increase of 836.82.
- For Enterprise Value (Cr.), as of Dec 23, the value is 2,210.85. It has increased from 1,039.64 (Dec 22) to 2,210.85, marking an increase of 1,171.21.
- For EV / Net Operating Revenue (X), as of Dec 23, the value is 4.63. This value exceeds the healthy maximum of 3. It has increased from 2.56 (Dec 22) to 4.63, marking an increase of 2.07.
- For EV / EBITDA (X), as of Dec 23, the value is 24.26. This value exceeds the healthy maximum of 15. It has increased from 14.80 (Dec 22) to 24.26, marking an increase of 9.46.
- For MarketCap / Net Operating Revenue (X), as of Dec 23, the value is 5.11. This value exceeds the healthy maximum of 3. It has increased from 3.02 (Dec 22) to 5.11, marking an increase of 2.09.
- For Retention Ratios (%), as of Dec 23, the value is 64.99. This value is within the healthy range. It has decreased from 65.26 (Dec 22) to 64.99, marking a decrease of 0.27.
- For Price / BV (X), as of Dec 23, the value is 8.52. This value exceeds the healthy maximum of 3. It has increased from 5.14 (Dec 22) to 8.52, marking an increase of 3.38.
- For Price / Net Operating Revenue (X), as of Dec 23, the value is 5.11. This value exceeds the healthy maximum of 3. It has increased from 3.02 (Dec 22) to 5.11, marking an increase of 2.09.
- For EarningsYield, as of Dec 23, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Dec 22) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Foseco India Ltd:
- Net Profit Margin: 15.28%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 28.89% (Industry Average ROCE: 14.38%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 25.46% (Industry Average ROE: 10.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 836.82
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.59
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 42.9 (Industry average Stock P/E: 432.65)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 15.28%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Gat Nos. 922 & 923, Pune District Maharashtra 412208 | investor.grievance@vesuvius.com http://www.fosecoindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Moti Kirpalani | Chairperson & Director |
| Mr. Prasad Chavare | Managing Director & CEO |
| Mr. Mark Russel Collis | Director |
| Ms. Anita Belani | Director |
| Ms. Karena Cancilleri | Director |
| Mr. Amitabha Mukhopadhyay | Director |
FAQ
What is the intrinsic value of Foseco India Ltd?
Foseco India Ltd's intrinsic value (as of 10 October 2025) is 4650.84 which is 15.44% lower the current market price of 5,500.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,515 Cr. market cap, FY2025-2026 high/low of 6,846/3,205, reserves of ₹363 Cr, and liabilities of 522 Cr.
What is the Market Cap of Foseco India Ltd?
The Market Cap of Foseco India Ltd is 3,515 Cr..
What is the current Stock Price of Foseco India Ltd as on 10 October 2025?
The current stock price of Foseco India Ltd as on 10 October 2025 is 5,500.
What is the High / Low of Foseco India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Foseco India Ltd stocks is 6,846/3,205.
What is the Stock P/E of Foseco India Ltd?
The Stock P/E of Foseco India Ltd is 42.9.
What is the Book Value of Foseco India Ltd?
The Book Value of Foseco India Ltd is 579.
What is the Dividend Yield of Foseco India Ltd?
The Dividend Yield of Foseco India Ltd is 0.45 %.
What is the ROCE of Foseco India Ltd?
The ROCE of Foseco India Ltd is 31.3 %.
What is the ROE of Foseco India Ltd?
The ROE of Foseco India Ltd is 23.3 %.
What is the Face Value of Foseco India Ltd?
The Face Value of Foseco India Ltd is 10.0.